Bank of New York Mellon Corp - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 29 filers reported holding AGILE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$9,000
-55.0%
40,6670.0%0.00%
Q4 2021$20,000
-48.7%
40,6670.0%0.00%
Q3 2021$39,000
-43.5%
40,667
-21.3%
0.00%
Q2 2021$69,000
-83.1%
51,667
-73.6%
0.00%
Q1 2021$408,000
-28.2%
195,949
-0.9%
0.00%
Q4 2020$568,000
-10.4%
197,821
-5.3%
0.00%
Q3 2020$634,000
+8.6%
208,862
-0.6%
0.00%
Q2 2020$584,000
+467.0%
210,048
+276.1%
0.00%
Q1 2020$103,000
-23.7%
55,855
+3.8%
0.00%
Q4 2019$135,000
+275.0%
53,834
+74.6%
0.00%
Q3 2019$36,000
-20.0%
30,8290.0%0.00%
Q2 2019$45,000
-4.3%
30,8290.0%0.00%
Q1 2019$47,000
+161.1%
30,829
-2.0%
0.00%
Q4 2018$18,000
+63.6%
31,4540.0%0.00%
Q3 2018$11,000
-26.7%
31,4540.0%0.00%
Q2 2018$15,000
-83.1%
31,454
-8.7%
0.00%
Q1 2018$89,000
-15.2%
34,454
-11.5%
0.00%
Q4 2017$105,000
+29.6%
38,920
+113.1%
0.00%
Q3 2017$81,000
+14.1%
18,266
-4.7%
0.00%
Q2 2017$71,000
-61.0%
19,161
-66.2%
0.00%
Q1 2017$182,000
-49.6%
56,657
-10.6%
0.00%
Q4 2016$361,000
-16.8%
63,353
+1.9%
0.00%
Q3 2016$434,000
-10.3%
62,188
-2.2%
0.00%
Q2 2016$484,000
+36.3%
63,612
+11.1%
0.00%
Q1 2016$355,000
-13.0%
57,257
+37.1%
0.00%
Q4 2015$408,000
+44.7%
41,7730.0%0.00%
Q3 2015$282,000
+3.7%
41,773
+31.8%
0.00%
Q2 2015$272,00031,7010.00%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Perceptive Advisors 15,919,925$33,113,0000.42%
INVESTOR AB 3,510,189$7,301,0000.26%
NEEDHAM INVESTMENT MANAGEMENT LLC 735,000$1,529,0000.21%
FIRST MIDWEST BANK TRUST DIVISION 578,864$1,204,0000.17%
PREMIER ASSET MANAGEMENT LLC 224,559$467,0000.08%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 100,000$208,0000.06%
GSA CAPITAL PARTNERS LLP 140,015$291,0000.05%
NEXPOINT ASSET MANAGEMENT, L.P. 25,000$52,0000.01%
Kalos Management, Inc. 19,250$35,0000.01%
Founders Capital Management 5,000$10,0000.01%
View complete list of AGILE THERAPEUTICS INC shareholders